ClinicalTrials.gg
CompletedNCT06059599Updated Oct 9, 2026

Active Informed Consent: a New Solution to Improve and Objectively Test the Patient Understanding of Complex Surgical Procedures Proposals

An interventional study of active informed consent in Spine Disease and Urologic Diseases, sponsored by Istituto Ortopedico Rizzoli. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Health services research

Updated Oct 9, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is an interventional, non-pharmacological, randomized controlled superiority study (RCT), multicenter, open label, parallel group.

The aim is to evaluate the effectiveness of a new preoperative information method, based on multimedia tools and on the objective control of understanding by the patient candidate for spinal or urological surgery.

02

Conditions studied

  • Spine Disease
  • Urologic Diseases
03

In context

Spinal Diseases

174 studies on the registry are indexed under Spinal Diseases; 39 are open to participants now.

This study's enrollment of 300 is above the median of 60 across 106 interventional studies indexed under Spinal Diseases.

Browse Spinal Diseases studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged ≥ 18 years (with full legal capacity to consent).
  • Scheduled for elective surgery in one of the two domains: spinal surgery or radical prostatectomy in the waiting list of our centers.
  • Ability to comprehend Italian language.
  • Basic computer or internet access skills. Patients (or their family members) should have the ability to access multimedia content.

Exclusion criteria

Exclusion Criteria:

  • Patients under age: minors.
  • Inability to provide or self-determination (significant cognitive impairment, severe mental illness, or decisional incapacity that would prevent them from understanding the consent materials or participating in the decision-making).
  • Urgent or emergency surgery cases.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (actual)

Study arms

  • Experimental
    active informed consent

    The experimental group will be prepared for the surgery through the new information tools, a video will be administered with information about the various surgical possibilities, graphics and animations in order to direct the patient toward a more informed choice. Next, an interview with the surgeon will be arranged for the patient and care givers to be listened to and guided through the use of 3D-printed models into the best decision for the individual case (Shared Decision Making - SDM). Having decided on the surgery, patients with similar surgical programs will be guided in educational programs to reinforce information, understanding and long-term retention of the concepts learned. The course will conclude with a second interview with the surgeon and the signing of the standard informed consent.

    Other: active informed consent

  • No intervention
    Traditional informed consent

    The control group of patients will be informed about the surgery according to standard practices. As per standard practice, the patient will meet with the physician before surgery for an explanatory interview and subsequent signing of informed consent.

Interventions

  • Otheractive informed consent

    new preoperative information method, based on multimedia tools and on the objective control of understanding by the patient candidate for vertebral or urological surgery.

06

What researchers measure

Primary outcomes

  1. Client Satisfaction Questionnaire

    The primary outcome of the study will be measured: - by means of the Client Satisfaction Questionnaire, which provides a patient satisfaction score with a range from a minimum of 8 points (completely dissatisfied) to a maximum of 32 points (completely satisfied).

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

Secondary outcomes

  1. Comprehension Questionnaire

    procedure-specific assessment tool designed ad-hoc to evaluate a patient's knowledge and understanding of the planned procedure and associated risks/alternatives.

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

  2. Depression Anxiety Stress Scales (DASS-21)

    is a 21-item self-report questionnaire designed to assess the severity of depression, anxiety, and stress symptoms over the past week

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

  3. Numeric Rating Scale (NRS)

    is a simple self-report measure in which patients rate their current pain intensity on an scale from 0 ("no pain") to 10 ("worst imaginable pain").

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

  4. Oswestry Disability Index (ODI)

    self-administered questionnaire that assesses the degree of disability and functional impairment across ten daily-activity domains.

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

  5. International Prostate Symptom Score (IPSS)

    Only for Urology patients: 7-item questionnaire that evaluates the severity of lower urinary tract symptoms and their impact on quality of life.

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

  6. International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF)

    Only for Urology patients: short, patient-completed questionnaire that measures the frequency, severity, and impact of urinary incontinence on quality of life.

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

  7. International Index of Erectile Function (IIEF-5 )

    Only for Urology patients: brief, 5-item self-report measure used to assess erectile function and screen for erectile dysfunction severity

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3)

  8. Rate of Patients Declining Spine Surgery (Opt-Out Rate)

    The proportion of patients in spine surgery population, who, after receiving full information, choose not to proceed with the planned surgery.

    Time frame: baseline (T0)

  9. Medico-Legal Outcomes

    For each group, we will track through hospital records the number of medicolegal complaints or claims filed by patients, specifically those alleging inadequate informed consent or unexpected outcomes, related to their surgery within the follow-up period. The outcome will be reported as the count (or proportion of patients) with such complaints in each arm.

    Time frame: baseline (T0), discharge (T1), 2 months follow-up (T2) and 6 months follow-up (T3).

07

Study locations

1 site
  • Istituto Ortopedico Rizzoli
    Bologna, 40136, Italy
08

References and documents

Publications

  • Kinnersley P, Phillips K, Savage K, Kelly MJ, Farrell E, Morgan B, Whistance R, Lewis V, Mann MK, Stephens BL, Blazeby J, Elwyn G, Edwards AG. Interventions to promote informed consent for patients undergoing surgical and other invasive healthcare procedures. Cochrane Database Syst Rev. 2013 Jul 6;2013(7):CD009445. doi: 10.1002/14651858.CD009445.pub2. PubMed 23832767 ↗
  • Glaser J, Nouri S, Fernandez A, Sudore RL, Schillinger D, Klein-Fedyshin M, Schenker Y. Interventions to Improve Patient Comprehension in Informed Consent for Medical and Surgical Procedures: An Updated Systematic Review. Med Decis Making. 2020 Feb;40(2):119-143. doi: 10.1177/0272989X19896348. Epub 2020 Jan 16. PubMed 31948345 ↗
  • Nathe JM, Krakow EF. The Challenges of Informed Consent in High-Stakes, Randomized Oncology Trials: A Systematic Review. MDM Policy Pract. 2019 Mar 28;4(1):2381468319840322. doi: 10.1177/2381468319840322. eCollection 2019 Jan-Jun. PubMed 30944886 ↗
  • Luhnen J, Muhlhauser I, Steckelberg A. The Quality of Informed Consent Forms-a Systematic Review and Critical Analysis. Dtsch Arztebl Int. 2018 Jun 1;115(22):377-383. doi: 10.3238/arztebl.2018.0377. PubMed 29932049 ↗
  • Boriani L, Quattrini I, Maccaferri B, Lima C, Benuzzi A, Salvador M, Schiavina R, Brunocilla E, Deiure F, Maselli V, De Stefano R, Vommaro F, Gasbarrini A. Protocol RCT for active informed consent in spine and urologic surgery in the metropolitan city of Bologna: does an increased patient engagement improve satisfaction of complex surgical procedures? BMJ Open. 2026 Mar 10;16(3):e108286. doi: 10.1136/bmjopen-2025-108286. PubMed 41806994 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 9, 2026
Primary completion
Sep 2026→Jul 1, 2025 (actual)
Oct 9, 2026
Study completion
Oct 2026→Aug 31, 2025 (actual)
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Recruiting→Completed
    Primary completion Sep 2026→Jul 1, 2025 (now actual)
    Study completion Oct 2026→Aug 31, 2025 (now actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06059599
Responsible party
Sponsor
First posted
Sep 28, 2023
Start date
Jun 19, 2024
Primary completion
Jul 1, 2025
Completion
Aug 31, 2025
Last update
Oct 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion